Dyne Therapeutics, Inc. (DYN)
16.70
+0.28
(+1.74%)
USD |
NASDAQ |
Jan 16, 16:00
16.99
+0.28
(+1.71%)
Pre-Market: 08:59
Dyne Therapeutics EPS Diluted (Quarterly): -0.7619 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | -1.265 |
| Structure Therapeutics, Inc. | -1.125 |
| MannKind Corp. | 0.0256 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Denali Therapeutics, Inc. | -0.736 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.04M |
| Total Expenses (Quarterly) | 108.04M |
| Enterprise Value | 1.714B |
| Earnings Yield | -21.91% |
| Normalized Earnings Yield | -21.91 |